Semax/Semax acetate/ACTH (4-7), Pro-Gly-Pro- CAS 80714-61-0 use to treat stroke and transient ischemic attacks

Semax/Semax acetate/ACTH (4-7), Pro-Gly-Pro- CAS 80714-61-0 use to treat stroke and transient ischemic attacks

Product Name: Semax/Semax acetate/ACTH (4-7), Pro-Gly-Pro-
Synonyms: ACTH (4-7), Pro-Gly-Pro-;ACTH (4-7), Pro-Gly-Pro trifluoroacetate salt;L-Methionyl-L-a-glutamyl-L-histidyl-L-phenylalanyl-L-prolylglycyl-L-proline trifluoroacetate salt;Met-Glu-His-Phe-Pro-Gly-Pro;Semax;(PRO8,GLY9,PRO10)ACTH-(4-10);SemaxAcetate;L-METHIONYL-L-Α-GLUTAMYL-L-HISTIDYL-L-PHENYLALANYL-L-PROLYLGLYCYL-L-PROLINE
CAS: 80714-61-0
MF: C37H51N9O10S
MW: 813.92
EINECS:
Product Categories:
Mol File: 80714-61-0.mol

Semax is a drug produced and prescribed mostly in Russia and Ukraine for a broad range of conditions but predominantly for its purported nootropic, neuroprotective, and neurogenic/neurorestorative properties. It is a heptapeptide, synthetic analog of a fragment of adrenocorticotropic hormone (ACTH), ACTH (4-10), of the following structure: Met-Glu-His-Phe-Pro-Gly-Pro. Semax has not been evaluated by the U.S. FDA. It is unscheduled in the U.S. and legal to import by private citizens for personal use

Remarks: This product is limited for lab research purpose only.

Semax/Semax acetate/ACTH (4-7), Pro-Gly-Pro- CAS 80714-61-0 Chemical Properties
Boiling point 1335.2±65.0 °C(Predicted)
density 1.391±0.06 g/cm3(Predicted)
storage temp. -20°C
solubility H2O: >2mg/mL
form powder
pka 3.43±0.20(Predicted)
color white to tan

Uses of Semax/Semax acetate/ACTH (4-7), Pro-Gly-Pro- CAS 80714-61-0
Semax has undergone extensive study in Russia and is on the Russian List of Vital & Essential Drugsapproved by the Russian Federation government on December 7, 2011.[1] Medical uses for Semax include treatment of stroke, transient ischemic attack, memory and cognitive disorders, peptic ulcers, optic nerve disease, and to boost the immune system.